Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes

Immunology and Cell Biology

Volumn 89, Issue 1, 2011, Pages 45-53

  Wirnsberger, Gerald ^a   Hinterberger, Maria ^a   Klein, Ludger ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

clonal deletion; negative selection; regulatory T cell; T cell development; thymus

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

APOPTOSIS; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CLONAL VARIATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; THYMOCYTE; THYMUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; CELL DIFFERENTIATION; CLONAL DELETION; CYTOKINES; HUMANS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 78651091811     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.123     Document Type: Review

References (116)

1. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273-280.
2. +8+ thymocytes. Nature 1988; 333: 742-746.
3. Burnet FM. A modification of Jernes theory of antibody production using the concept of clonal selection. Aust J Sci 1957; 20: 67-69.
4. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006; 24: 571-606.
5. Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008; 8: 948-957.
6. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009; 27: 287-312.
7. Consortium TF-GA. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997; 17: 399-403.
8. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-398.
9. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30: 616-625.
10. Germain RN. Special regulatory T-cell review: a rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology 2008; 123: 20-27.
11. Coutinho A. The Le Douarin phenomenon: a shift in the paradigm of developmental self-tolerance. Int J Dev Biol 2005; 49: 131-136.
12. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562.
13. +CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2: 301-306.
14. + CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J Immunol 2004; 173: 236-244.
15. Picca CC, Oh S, Panarey L, Aitken M, Basehoar A, Caton AJ. Thymocyte deletion can bias Treg formation toward low-abundance self-peptide. Eur J Immunol 2009; 39: 3301-3306.
16. Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, Miyazaki J et al. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive Tcells by endogenous TCR expression. J Immunol 2002; 168: 4399-4405.
17. Aschenbrenner K, DCruz LM, Vollmann EH, Hinterberger M, Emmerich J, Swee LK et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007; 8: 351-358.
18. Peterson DA, DiPaolo RJ, Kanagawa O, Unanue ER. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells. J Immunol 1999; 162: 3117-3120.
19. van Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J ExpMed 2004; 200: 1221-1230.
20. Liston A, Lesage S, Gray DH, OReilly LA, Strasser A, Fahrer AM et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 2004; 21: 817-830.
21. Atibalentja DF, Byersdorfer CA, Unanue ER. Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction. J Immunol 2009; 183: 7909-7918.
22. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10: 371-378.
23. Ribot J, Romagnoli P, van Meerwijk JP. gonist ligands expressed by thymic epithelium enhance positive selection of regulatory T lymphocytes from precursors with a normally diverse TCR repertoire. J Immunol 2006; 177: 1101-1107.
24. + T cell receptors. Immunity 2004; 21: 267-277.
25. Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immunol 2006; 7: 401-410.
26. Romagnoli P, Hudrisier D, van Meerwijk JP. Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J Immunol 2002; 168: 1644-1648.
27. Pacholczyk R, Kern J, Singh N, Iwashima M, Kraj P, Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity 2007; 27: 493-504.
28. Leung MW, Shen S, Lafaille JJ. TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes. J Exp Med 2009; 206: 2121-2130.
29. Bautista JL, Lio CW, Lathrop SK, Forbush K, Liang Y, Luo J et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol 2009; 10: 610-617.
30. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J et al. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 2000; 192: 1105-1113.
31. Smith AL, Wikstrom ME, Fazekas de St Groth B. Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. Immunity 2000; 13: 783-794.
32. + T cell proliferation and effector function in vivo. Immunity 2000; 13: 291-301.
33. +CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-440.
34. +CD25+ regulatory T cells. J Immunol 2003; 171: 3348-3352.
35. Lohr J, Knoechel B, Kahn EC, Abbas AK. Role of B7 in T cell tolerance. J Immunol 2004; 173: 5028-5035.
36. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6: 152-162.
37. Lio CW, Dodson LF, Deppong CM, Hsieh CS, Green JM. CD28 facilitates the generation of Foxp3- cytokine responsive regulatory T cell precursors. J Immunol 2010; 184: 6007-6013
38. Buhlmann JE, Elkin SK, Sharpe AH. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. J Immunol 2003; 170: 5421-5428.
39. +8+ thymocytes. J Immunol 1992; 149: 3217-3224.
40. + thymocytes. J Immunol 1993; 151: 1868-1880.
41. Dautigny N, Le Campion A, Lucas B. Timing and casting for actors of thymic negative selection. J Immunol 1999; 162: 1294-1302.
42. Walunas TL, Sperling AI, Khattri R, Thompson CB, Bluestone JA. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J Immunol 1996; 156: 1006-1013.
43. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-547.
44. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985-988.
45. Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 1999; 163: 1128-1131.
46. Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER et al. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol 2010; 11: 129-135.
47. Waterhouse P, Bachmann MF, Penninger JM, Ohashi PS, Mak TW. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptortransgenic CTLA-4-deficient mice. Eur J Immunol 1997; 27: 1887-1892.
48. Chambers CA, Cado D, Truong T, Allison JP. Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9296-9301.
49. Takahashi S, Kataoka H, Hara S, Yokosuka T, Takase K, Yamasaki S et al. In vivo overexpression of CTLA-4 suppresses lymphoproliferative diseases and thymic negative selection. Eur J Immunol 2005; 35: 399-407.
50. Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183: 2533-2540.
51. Brunner MC, Chambers CA, Chan FK, Hanke J, Winoto A, Allison JP. CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813-5820.
52. Linsley PS, Golstein P. Lymphocyte activation: T-cell regulation by CTLA-4. Curr Biol 1996; 6: 398-400.
53. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-2550.
54. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 2008; 105: 7797-7802.
55. Wirnsberger G, Mair F, Klein L. Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control. Proc Natl Acad Sci USA 2009; 106: 10278-10283.
56. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991; 352: 621-624.
57. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268: 1472-1476.
58. Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med 1999; 190: 1561-1572.
59. Kramer S, Schimpl A, Hunig T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995; 182: 1769-1776.
60. + T cell numbers. J Immunol 2002; 169: 4850-4860.
61. Bayer AL, Yu A, Adeegbe D, Malek TR. Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period. J Exp Med 2005; 201: 769-777.
62. +regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005; 201: 723-735.
63. Liston A, Siggs OM, Goodnow CC. Tracing the action of IL-2 in tolerance to isletspecific antigen. Immunol Cell Biol 2007; 85: 338-342.
64. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142-1151.
65. DCruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005; 6: 1152-1159.
66. + T regulatory cells. J Immunol 2008; 181: 225-234.
67. +Foxp3+ regulatory T cell development. J Immunol 2008; 181: 3285-3290.
68. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007; 109: 4368-4375.
69. Lio CW, Hsieh CS. A two-step process for thymic regulatory T cell development. Immunity 2008; 28: 100-111.
70. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008; 28: 112-121.
71. +CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
72. +CD25-T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149-5153.
73. +CD25- precursors. J Immunol 2002; 169: 4183-4189.
74. Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell 2008; 134: 392-404.
75. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006; 25: 455-471.
76. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006; 25: 441-454.
77. +CD25+ regulatory T cells. J Exp Med 2005; 201: 1061-1067.
78. + regulatory T cells. Nat Immunol 2008; 9: 632-640.
79. Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010; 32: 642-653.
80. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9: 194-202.
81. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463: 808-812.
82. Ebert PJ, Ehrlich LI, Davis MM. Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation. Immunity 2008; 29: 734-745.
83. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003; 21: 139-176.
84. Degermann S, Surh CD, Glimcher LH, Sprent J, Lo D. B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes. J Immunol 1994; 152: 3254-3263.
85. Nelson AJ, Hosier S, Brady W, Linsley PS, Farr AG. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J Immunol 1993; 151: 2453-2461.
86. Reiser H, Schneeberger EE. The costimulatory molecule B7 is expressed in the medullary region of the murine thymus. Immunology 1994; 81: 532-537.
87. + T regulatory cells. J Immunol 2006; 177: 5115-5121.
88. Yang-Snyder JA, Rothenberg EV. Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice. Dev Immunol 1998; 5: 223-245.
89. Fontenot JD, Dooley JL, Farr AG, Rudensky AY. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 202: 901-906.
90. + subset. J Immunol 2009; 183: 2261-2266.
91. Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, Koni PA et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci USA 2008; 105: 11903-11908.
92. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 2001; 194: 427-438.
93. Kishimoto H, Sprent J. Negative selection in the thymus includes semimature T cells. J Exp Med 1997; 185: 263-271.
94. Anderson G, Lane PJ, Jenkinson EJ. Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol 2007; 7: 954-963.
95. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 2009; 9: 833-844.
96. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1032-1039.
97. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298: 1395-1401.
98. Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 2004; 200: 1039-1049.
99. Klein L, Klein T, Ruther U, Kyewski B. CD4T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998; 188: 5-16.
100. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4: 350-354.
101. +T cell tolerance. Nat Immunol 2010; 11: 512-519.
102. Koble C, Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med 2009; 206: 1505-1513.
103. van Meerwijk JP, Marguerat S, Lees RK, Germain RN, Fowlkes BJ, MacDonald HR. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med 1997; 185: 377-383.
104. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206: 549-559.
105. +CD25+ regulatory T cells in human thymus. Nature 2005; 436: 1181-1185.
106. Hanabuchi S, Ito T, Park WR, Watanabe N, Shaw JL, Roman E et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 2010; 184: 2999-3007.
107. Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010; 115: 5366-5375.
108. Proietto AI, van Dommelen S, Zhou P, Rizzitelli A, DAmico A, Steptoe RJ et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci USA 2008; 105: 19869-19874.
109. Wu L, Shortman K. Heterogeneity of thymic dendritic cells. Semin Immunol 2005; 17: 304-312.
110. Relland LM, Mishra MK, Haribhai D, Edwards B, Ziegelbauer J, Williams CB. Affinitybased selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression. J Immunol 2009; 182: 1341-1350.
111. Simons DM, Picca CC, Oh S, Perng OA, Aitken M, Erikson J et al. How specificity for selfpeptides shapes the development and function of regulatory T cells. J Leukoc Biol 2010 (e-pub ahead of print; doi:10.1189/jlb.0310183).
112. Feuerer M, Jiang W, Holler PD, Satpathy A, Campbell C, Bogue M et al. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc Natl Acad Sci USA 2007; 104: 18181-18186.
113. Grossman Z, Singer A. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc Natl Acad Sci USA 1996; 93: 14747-14752.
114. Stojakovic M, Salazar-Fontana LI, Tatari-Calderone Z, Badovinac VP, Santori FR, Kovalovsky D et al. Adaptable TCR avidity thresholds for negative selection. J Immunol 2008; 181: 6770-6778.
115. Wong P, Barton GM, Forbush KA, Rudensky AY. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J Exp Med 2001; 193: 1179-1187.
116. Palmer E, Naeher D. Affinity threshold for thymic selection through a T-cell receptorco- receptor zipper. Nat Rev Immunol 2009; 9: 207-213.